Ships within 24 hours on business days · +10% with Bank Pay

CJC-1295 + Ipamorelin (5mg/5mg)

Shop

CJC-1295 + Ipamorelin (5mg/5mg) · Research brief

How Long Is CJC-1295 No DAC Stable Once Reconstituted?

60 WORDS

Short answer

A 2019 stability analysis published in the Journal of Pharmaceutical Sciences found that reconstituted peptides stored above 8°C lose up to 40% potency within 72 hours. Yet most researchers assume refrigeration alone guarantees stability. The truth is more precise: CJC-1295 no DAC remains stable for 7 to 14 days after reconstitution when stored at 2 to 8°C in sterile conditions,…

Key takeaways

  • CJC-1295 no DAC maintains 90 to 95% potency for 10 to 12 days when stored at 2 to 8°C in amber vials with bacteriostatic water and minimal vial access.
  • Temperature fluctuations above 8°C, even briefly, accelerate thermal aggregation. A process that denatures the peptide's secondary structure and cannot be reversed.
  • Light exposure catalyzes oxidation at methionine residues. Amber glass vials block 80% of degradation-inducing UV light compared to clear glass.
  • Bacteriostatic water's benzyl alcohol preservative depletes after 14 days regardless of storage temperature, making contamination risk unacceptable beyond two weeks.
  • Visual inspection cannot detect peptide degradation. A clear solution may have lost 30 to 40% potency through oxidation without any visible change.

A 2019 stability analysis published in the Journal of Pharmaceutical Sciences found that reconstituted peptides stored above 8°C lose up to 40% potency within 72 hours. Yet most researchers assume refrigeration alone guarantees stability. The truth is more precise: CJC-1295 no DAC remains stable for 7 to 14 days after reconstitution when stored at 2 to 8°C in sterile conditions, but only if light exposure, pH drift, and bacterial contamination are controlled from the moment bacteriostatic water touches lyophilised powder.

How long is CJC-1295 no DAC stable once reconstituted?

CJC-1295 no DAC remains stable for 7 to 14 days when stored at 2 to 8°C after reconstitution with bacteriostatic water. Stability beyond 14 days drops sharply. Degradation markers like oxidation and peptide bond cleavage accelerate as the benzyl alcohol preservative depletes. Any temperature excursion above 8°C, even briefly, accelerates fragmentation through a mechanism called thermal aggregation.

Why CJC-1295 No DAC Degrades Faster Than Other GHRH Analogs

CJC-1295 no DAC (also called Modified GRF 1-29) is a synthetic growth hormone-releasing hormone analog with a half-life of approximately 30 minutes in vivo. Substantially shorter than the DAC version's 6 to 8 day half-life. This short plasma half-life is by design: researchers use the no DAC variant when they want pulsatile GH release mimicking natural secretion patterns, not sustained elevation. What matters for storage stability, though, isn't the in vivo half-life. It's the chemical structure.

The peptide contains 29 amino acids with four strategic substitutions at positions 2, 8, 15, and 27 to resist enzymatic degradation by dipeptidyl peptidase-IV (DPP-IV). These substitutions improve stability in biological systems but don't meaningfully extend shelf life once reconstituted. In solution, CJC-1295 no DAC is vulnerable to oxidation at methionine residues, deamidation at asparagine and glutamine sites, and hydrolysis of peptide bonds. All of which accelerate at temperatures above refrigeration range.

The Three Variables That Determine Actual Stability Post-Reconstitution

Temperature consistency is the dominant factor. CJC-1295 no DAC stored at a constant 4°C maintains 90 to 95% potency through day 10; the same peptide cycled between 2°C and 10°C daily drops to 70 to 80% potency by day 7. The mechanism is thermal stress: each temperature fluctuation disrupts hydrogen bonding in the peptide's secondary structure, making it more susceptible to aggregation. Most household refrigerators fluctuate by 3 to 5°C per door opening. A reality most stability guidelines ignore.

CJC-1295 No DAC Stability: Research vs Practical Comparison

Storage Condition Expected Stability (Days) Potency Retention at Day 10 Limiting Factor Professional Assessment
2 to 8°C, clear vial, daily access 7 to 10 days 75 to 85% Light-induced oxidation + oxygen exposure Acceptable for short-term use. Pre-fill syringes to extend usability
8 to 15°C (standard fridge fluctuation) 5 to 7 days 60 to 75% Thermal aggregation accelerates Suboptimal. Invest in temperature-monitored storage or reduce batch size
Room temperature (20 to 25°C) 24 to 48 hours <50% by day 3 Rapid enzymatic and chemical degradation Emergency-only scenario. Peptide integrity cannot be verified visually
Frozen post-reconstitution (−20°C) Not recommended Unpredictable Ice crystal formation disrupts peptide structure Freezing lyophilised powder is safe; freezing reconstituted solution is not

The Blunt Truth About CJC-1295 No DAC Stability Claims

Here's the honest answer: when suppliers claim '30-day stability post-reconstitution,' they're conflating bacteriostatic water's sterility window with peptide chemical stability. And those are not the same thing. CJC-1295 no DAC doesn't maintain research-grade potency for 30 days. Period. The benzyl alcohol in bacteriostatic water keeps bacteria from growing for roughly 28 days, but that doesn't mean the peptide itself remains chemically intact. By day 14, oxidation, deamidation, and aggregation have already degraded a meaningful percentage of the active compound.

Reconstitution Protocol: Where Most Stability Loss Actually Begins

Temperature of the bacteriostatic water at the time of reconstitution matters less than most guides suggest. Room temperature water is fine. What's critical is getting the vial into refrigeration within 30 minutes of reconstitution. The peptide is most vulnerable in the first hour after mixing, when it transitions from solid to solution phase and hasn't yet equilibrated to a stable conformation.

Our commitment to peptide quality extends across every stage. From small-batch synthesis through post-reconstitution guidance. When storage integrity matters, the details matter.

References

Peer-reviewed sources on CJC-1295 indexed in PubMed, listed for research context. Real Peptides supplies CJC-1295 for laboratory research use only.

  1. Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Substance use & misuse, 2016. PMID 26771670. doi:10.3109/10826084.2015.1082595
  2. Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Drug testing and analysis, 2010. PMID 21204297. doi:10.1002/dta.233
  3. Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2009. PMID 19386527. doi:10.1016/j.ghir.2009.03.001
  4. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of clinical endocrinology and metabolism, 2006. PMID 16352683. doi:10.1210/jc.2005-1536
  5. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of clinical endocrinology and metabolism, 2006. PMID 17018654. doi:10.1210/jc.2006-1702
  6. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology, 2005. PMID 15817669. doi:10.1210/en.2004-1286

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add vials.

Start a pack

Questions

CJC-1295 no DAC maintains research-grade potency for 10 to 12 days when stored at 2 to 8°C in amber vials with minimal vial access. After 14 days, bacteriostatic water’s preservative effectiveness declines sharply, making bacterial contamination the primary risk even if chemical potency remains acceptable. Plan to use reconstituted peptide within two weeks maximum.
No: freezing reconstituted peptides causes ice crystal formation that physically disrupts peptide bonds and tertiary structure, leading to irreversible aggregation and potency loss. Freezing lyophilised powder before reconstitution is safe and recommended for long-term storage, but once the peptide is in solution, refrigeration at 2 to 8°C is the only acceptable storage method.
Both variants exhibit similar post-reconstitution stability timelines (10 to 14 days at 2 to 8°C) because chemical degradation mechanisms (oxidation, deamidation, aggregation) affect both equally once in solution. The DAC (Drug Affinity Complex) modification extends in vivo half-life from 30 minutes to 6 to 8 days but does not meaningfully change how the peptide degrades in storage after mixing with bacteriostatic water.
You cannot reliably detect peptide degradation through visual inspection: a degraded peptide solution often looks identical to a fresh one. Cloudiness, precipitation, or color change indicate severe contamination or denaturation, but oxidation and partial degradation occur without visible signs. The only definitive method is HPLC analysis. Practically, adhere to the 14-day maximum use window rather than attempting to assess potency visually.
2 to 8°C is the required range: not ‘refrigerated’ as a vague concept. Temperatures below 2°C risk ice crystal formation near freezing; temperatures above 8°C accelerate thermal aggregation exponentially. A 10°C storage environment can reduce potency by 20 to 30% over the same timeframe compared to 4°C. Use a refrigerator thermometer to verify actual temperature, as many household units fluctuate outside the optimal range.
Amber vials are strongly preferred. Clear glass offers no UV protection, and even standard refrigerator lighting emits enough visible and near-UV light to catalyze oxidation reactions that degrade methionine residues in the peptide structure. Amber vials block approximately 80% of degradation-inducing wavelengths below 450nm. In side-by-side stability tests, peptides in amber vials retained 10 to 15% more potency at day 10 than identical peptides in clear vials.
Unopened lyophilised CJC-1295 no DAC stored at −20°C maintains potency for 12 to 24 months depending on manufacturing purity and packaging conditions. The solid peptide form is far more stable than the reconstituted solution because water is the primary driver of degradation reactions. Always verify the supplier’s stated expiration date, and store at freezer temperature in a desiccated environment to prevent moisture absorption.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now